Eversept Partners’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,006
Closed -$305K 65
2022
Q4
$305K Hold
1,006
0.03% 58
2022
Q3
$55.5K Hold
1,006
﹤0.01% 59
2022
Q2
$60.1K Hold
1,006
﹤0.01% 65
2022
Q1
$115K Buy
1,006
+6
+0.6% +$684 0.01% 75
2021
Q4
$144K Buy
+1,000
New +$144K 0.01% 90